In 2005, the first GLP-1 got FDA approval to manage type 2 diabetes due to its ability to keep blood sugar stable, with others soon following
At IV Boost UK, many of our vitamin drips contain B12, but we also offer a B12 vitamin shot to those who want instant delivery of this powerhouse vitamin to exactly where it is needed
Given the market potential, strategic focus, and compelling clinical data, LLY stock represents a strong investment opportunity in the evolving obesity treatment landscape
The reason we say subjectively small is because every single person is different
212,213 The ongoing SURPASS-CVOT trial (NCT04255433) and SURPASS-CVOT trial (NCT06779929) aim to evaluate the impact of tirzepatide on cardiovascular outcomes compared with dulaglutide in patients with type 2 diabetes
It targets liver metabolism directly but does not address the root cause: obesity and insulin resistance